| |
Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes 1 1 Abbreviations: PPAR, peroxisome proliferator-activated receptor; 15d-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; NEFA, non-esterified fatty acid; T2DM, type 2 (non-insulin-dependent) diabetes mellitus; LPS, lipopolysaccharide; NSAIDs, nonsteroidal anti-inflammatory drugs; IL, interleukin; TNF α, tumor necrosis factor-α; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; and TZD, thiazolidinedione.
|
| |
|
|
| |
| Title: |
Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes 1 1 Abbreviations: PPAR, peroxisome proliferator-activated receptor; 15d-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; NEFA, non-esterified fatty acid; T2DM, type 2 (non-insulin-dependent) diabetes mellitus; LPS, lipopolysaccharide; NSAIDs, nonsteroidal anti-inflammatory drugs; IL, interleukin; TNF α, tumor necrosis factor-α; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; and TZD, thiazolidinedione.
|
| Author: |
Boelsterli, Urs A.
Bedoucha, Marc
|
| Appeared in: |
Biochemical pharmacology
|
| Paging: |
Volume 63 (2002) nr. 1 pages 10 p. |
| Year: |
2002
|
| Contents: |
|
| Publisher: |
Elsevier Science Inc.
|
| Source file: |
Elektronische Wetenschappelijke Tijdschriften
|
| |
|
|
| |
|
Journal description